Relative concentrations of hK2/PSA mRNA in benign and malignant prostatic tissue
Authors:
- 14 December 2004
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 63 (4) , 324-329
Abstract
BACKGROUND Prostate‐specific antigen (PSA/KLK3) and human kallikrein 2 (hK2/KLK2) belong to the human kallikrein gene family. These two highly homologous genes are specifically expressed in the prostate under androgen control. Expression of these is regulated by similar mechanisms but changes in their relative expression have been observed in prostate cancer. METHODS We determined the relative levels of PSA and hK2 mRNA in benign and malignant prostate tissue using a quantitative reverse transcription‐polymerase chain reaction (RT‐PCR) method. The mRNA of PSA and hK2 are reverse transcribed and amplified in one reaction with the same primers. RESULTS The variation in the ratio of hK2/PSA mRNA was remarkably small, the difference between the highest and lowest values being three‐fold. The ratio was significantly higher in WHO grade 2 compared to normal or benign prostatic hyperplasia tissue (P = 0.032 and P = 0.035, respectively) and in grade 3 compared to normal or benign prostatic hyperplasia tissue (P = 0.006 in both). CONCLUSIONS The new quantitative RT‐PCR technique facilitates very accurate quantitation of the relative mRNA levels of homologous genes. Using this method we have shown that the ratio of hK2/PSA mRNA is higher in cancerous than in benign prostatic tissue.Keywords
This publication has 34 references indexed in Scilit:
- Real-Time RT-PCR for the Measurement of Prostate-Specific Antigen mRNA Expression in Benign Hyperplasia and Adenocarcinoma of ProstateClinical Chemistry and Laboratory Medicine (CCLM), 2003
- Comparison of human prostate specific glandular kallikrein 2 and prostate specific antigen gene expression in prostate with gene amplification and overexpression of prostate specific glandular kallikrein 2 in tumor tissueCancer, 2001
- Expression and Characterization of Trypsinogen Produced in the Human Male Genital TractThe American Journal of Pathology, 2000
- Decreased concentrations of prostate-specific antigen and human glandular kallikrein 2 in malignant versus nonmalignant prostatic tissueUrology, 2000
- Human glandular kallikrein 2 expression in prostate adenocarcinoma and lymph node metastasesUrology, 1999
- Tissue PSA from fine-needle biopsies of prostatic carcinoma as related to serum PSA, clinical stage, cytological grade, and DNA ploidyThe Prostate, 1999
- Human glandular kallikrein 2 (hK2) expression in prostatic intraepithelial neoplasia and adenocarcinoma: A novel prostate cancer markerUrology, 1997
- Tissue-specific and hormonal regulations of human prostate-specific glandular kallikreinBiochemistry, 1992
- In Situ Hybridization of Prostate-Specific Antigen mRNA in Human ProstateJournal of Urology, 1990
- Primary Structure of a Human Glandular Kallikrein GeneDNA, 1987